Medical and surgical treatment for secondary and tertiary hyperparathyroidism

Scandinavian Journal of Surgery

Volumn 93, Issue 4, 2004, Pages 288-297

  Schlosser, Katja ^a   Zielke, A ^a   Rothmund, M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Calcimimetics; Parathyroidectomy; Phosphate binders: autotransplantation

Indexed keywords

22 OXACALCITRIOL; BIOCHEMICAL MARKER; CALCIMIMETIC AGENT; CALCITRIOL; DOXERCALCIFEROL; FALECALCITRIOL; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT;

AUTOTRANSPLANTATION; CALCIUM METABOLISM; CHRONIC KIDNEY FAILURE; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; REVIEW; SECONDARY HYPERPARATHYROIDISM; TERTIARY HYPERPARATHYROIDISM; TREATMENT INDICATION;

EID: 11844292717     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690409300407     Document Type: Review

References (77)

1. Fassbinder W, Brunner FP, Brynger H, Ehrich JHH, Geerlings W, Raine AEG, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Combined report on regular dialysis and transplantation in Europe. XX, 1989. Nephrol Dial Transplant 6(Suppl 1):4-65, 1991
2. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F: Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 2001;12:1242-1248
3. Kestenbaum B, Seliger S.L., Gillen D.L., Wasse H, Young B, Sherrard DJ, Weiss N.S, Stehman-Breen C.O: Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int 2004;65:282-288
4. Jorna FH, Tobe TJ, Huisman RM, de Jong PE, Plukker JT, Stegeman CA: Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 2004;19:1168-1173
5. Slatopolsky E, Delmez JA: Pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant. 1996;11 (Suppl 3): 130-135
6. Dusso AS, Thadhani R, Slatopolsky E: Vitamin D receptor and analogs. Semin Nephrol 2004;24:10-6
7. Beckerman P, Silver J: Vitamin D and the parathyroid. Am J Med Sci 1999;317:363-369
8. Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H, Iida M: Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27. Nephrol Dial Transplant 2003;18 Suppl 3:iii9-12
9. 2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tiss Int 1988;43:213-218
10. Korkor AB: Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 1987;316:1573-1577
11. Jones G, Strugnell SA, DeLuca HF: Current understanding of the molecular actions of vitamin D. Physiol Rev 1998;78:1193-1231
12. Pearce SH: Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor. Ann Med 2002;34:201-206
13. Martin-Salvago M, Villar-Rodriguez JL, Palma-Alvarez A, Beato-Moreno A, Galera-Davidson H: Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure. Endocr Pathol 2003;14:61-1470
14. Chen RA, Goodman WG: Role of the calcium-sensing receptor in parathyroid gland physiology. Am J Physiol Renal Physiol 2004;286:F1005-1011
15. Malberti F, Farina M, Imbasciati E: The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transplant. 1999;14:2398-2406
16. Miyamoto K, Ito M, Segawa H, Kuwahata M: Secondary hyperparathyroidism and phosphate sensing in parathyroid glands. J Med Invest 2000;47:118-122
17. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ: Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996;97:2534-2540
18. Malmaeus J, Grimelius L, Johansson H, Akerstrom G, Ljunghall S: Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure. Scand J Urol Nephrol 1984;18:157-166
19. Yong JL, Vrga L, Warren BA: A study of parathyroid hyperplasia in chronic renal failure. Pathology 1994;26:99-109
20. Block GA, Port FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000;35:1226-1237
21. Goodman WG. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial 2004;17:209-216
22. Chou FF, Lee CH, Chen JB: General weakness as an indication for parathyroid surgery in patients with secondary hyperparathyroidism. Arch Surg 1999;134:1108-1111
23. Chou FF, Chee EC, Lee CH, Sheen-Chen SM: Muscle force, motor nerve conduction velocity and compound muscle action potentials after parathyroidectomy for secondary hyperparathyroidism. Acta Neurol Scand 2002;106:218-221
24. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR: Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med 1968;279:697-700
25. Chou FF, Ho JC, Huang SC, Sheen-Chen SM: A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 2000;190:65-70
26. Covic A, Florea L, Ungureanu C, Covic M: Renal osteodystrophy (II). Rev Med Chir Soc Med Nat Iasi 2000;104:21-25
27. Przedlacki J, Trebicka J, Bijak K, Matuszkiewicz-Rowinska J, Bogdanska-Straszynska B, Malecka G, Ostrowski K: Cross-linked C-terminal telopeptide of type I collagen in serum before and after treatment with alfacalcidol and calcium carbonate in early and moderate chronic renal failure. Nephron 2002;92:304-308
28. Pohlmeier R, Vienken J: Phosphate removal and hemodialysis conditions. Kidney Int Suppl 2001;78:190-194
29. Indridason OS, Quarles LD: Hyperphosphatemia in end-stage renal disease. Adv Ren Replace Ther 2002;9:184-192
30. Chertow GM, Burke SK, Dillon MA: Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients. Nephrol Dial Transplant 1999;14:2907-2914
31. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252
32. Hutchison AJ: Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy. Perit Dial Int 1999;19:408-412
33. Slatopolsky E, Dusso A, Brown A: New analogs of vitamin D3. Kidney Int Suppl 1999;73:46-51
34. Sprague SM, Lerma E, McCormmick D: Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol. Am J Kidney Dis 2001;38:51-56
35. 2 (Paricalcitol) safely and effectively reduces the levels of intact PTH in patients on hemodialysis. J Am Soc Nephrol 1998;9:1427-1432
36. Coburn JW, Maung HM, Elangovan L, Germain MJ, Lindberg JS, Sprague SM, Williams ME, Bishop CW: Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. Am J Kidney Dis 2004;43:877-890
37. Frazao JM, Elangovan L, Maung HM: Intermittent doxercalciferol (1α-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis 2000;36:550-561
38. Maung HM, Elangovan L, Frazao JM: Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: A sequential comparison. Am J Kidney Dis 2001;37:532-543
39. Akizawa T, Suzuki M, Akiba T: Long-term effect of 1,25-dihydroxy-22- oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study. Nephrol Dial Transplant 2002;17:28-36
40. Akiba T, Marumo F, Owada A: Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1998;32:238-246
41. Teng M, Wolf M, Lowrie E: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-456
42. Stanbury SW, Lumb GA, Nicholson WF: Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1960;1:793-799
43. Ogg CS: Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 1967;4:331-334
44. Geis WP, Popovtzer MM, Corman JL, Halgrimson CG, Groth CG, Starzi TE: The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet 973;137:997-1010
45. Wells SA Jr, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM: Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 1975;78:34-44
46. Ockert S, Willeke F, Richter A, Jonescheit J, Schnuelle P, Van Der Woude F, Post S: Total parathyroidectomy without autotransplantation as a standard procedure in the treatment of secondary hyperparathyroidism. Langenbecks Arch Surg 2002;387:204-209
47. Hampl H, Steinmuller T, Frohling P, Naoum C, Leder K, Stabeil U, Schnoy N, Jehle PM: Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure. Miner Electrolyte Metab 1999;25:161-170
48. Nicholson ML, Veitch PS, Feehally J: Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb 1996;41:382-387
49. Stracke S, Jehle PM, Sturm D, Schoenberg MH, Widmaier U, Beger HG, Keller F: Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 1999;33:304-311
50. Rothmund M, Wagner PK: Reoperations for persistent and recurrent secondary hyperparathyroidism. Ann Surg 1988;207:310-314.
51. Drueke TB, Zingraff J: The dilemma of parathyroidectomy in chronic renal failure. Curr Opin Nephrol Hypertens 1994;3:386-395
52. Rothmund M, Wagner PK, Schark C: Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991;15:745-750
53. Hampl H, Steinmuller T, Stabell U, Klingenberg HJ, Schnoy N, Neuhaus P: Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hemodialysis. Miner Electrolyte Metab 1991;17:256-260
54. Walgenbach S, Hommel G, Junginger T: Prospective evaluation of parathyroid graft function after total parathyroidectomy and heterotopic autotransplantation in renal hyperparathyroidism by bi-lateral determination of intact parathormone in cubital venous blood. World J Surg 998;22:93-97
55. Ljutic D, Cameron JS, Ogg CS, Turner C, Hicks JA, Owen WJ: Long-term follow-up after total parathyroidectomy without parathyroid reimplantation in chronic renal failure. QJM 1994;87:685-92
56. Skinner KA, Zuckerbraun L: Recurrent secondary hyperparathyroidism. An argument for total parathyroidectomy. Arch Surg 1996;131:724-727
57. Caccitolo JA, Farley DR, van Heerden JA, Grant CS, Thompson GB, Sterioff S: The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience. Surgery 1997;122:1062-1067
58. Herrera M, Grant C, van Heerden JA, Fitzpatrick LA: Parathyroid autotransplantation. Arch Surg 1992;127:825-9
59. Senapati A, Young AE. Parathyroid autotransplantation. Br J Surg 1990;77:1171-1174
60. Rothmund M, Wagner PK: Assessment of parathyroid graft function after autotransplantation of fresh and cryopreserved tissue. World J Surg. 1984;8:527-533
61. Schlosser K, Sitter H, Rothmund M, Zielke A: Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 2004;28:583-588.
62. Stehman-Breen C, Muirhead N, Thorning D, Sherrard D: Secondary hyperparathyroidism complicated by parathyromatosis. Am J Kidney Dis 1996;28:502-507
63. Kollmorgen CF, Aust MR, Ferreiro JA, McCarthy JT, van Heerden JA: Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery 1994;116:111-115
64. Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, Roher HD: Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 2003;387:348-354
65. Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I, Hachisuka T, Takagi H: More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 2001;38:168-171
66. Casanova D, Sarfati E, De Francisco A, Amado JA, Arias M, Dubost C: Secondary hyperparathyroidism: diagnosis of site of recurrence. World J Surg 1991;15:546-549
67. Knudsen L, Brandi L, Daugaard H, Olgaard K, Lockwood K: Five to 10 years follow-up after total parathyroidectomy and autotransplantation of parathyroid tissue: evaluation of parathyroid function by use of ischaemic blockade manoeuvre. Scand J Clin Lab Invest 1996;56:47-51
68. Diethelm AG, Edwards RP, Whechel JD: The natural history and surgical treatment of hypercalcaemia before and after renal transplantation. Surg Gynecol Obstet 1982;154:481-490
69. Dotzenrath C, Goretzki PE, Röher HD: Operative therapy of secondary hyperparathyroidism after renal transplantation. Langenbecks Arch Chir 1993;378:121-124
70. David DS, Sakai S et al: Hypercalcaemia after renal transplantation. Engl J Med 1973;289:398
71. D'Alessandro AM, Melzer JS et al: Tertiary hyperparathyroidism after renal transplantation: operative indications. Surgery 1989;106:1049-1056
72. Kerby JD, Rue LW, Blair H, Hudson S, Sellers MT, Diethelm AG: Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 1998;227:878-886
73. Alfrey AC, Jenkins D, Groth CG: Resolution of hyperparathyreoidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med 1968;279:1349
74. Johnson JW, Hattner RS, Hampers CL, et al: Secondary hyperparathyreoidism in chronic renal failure. JAMA 1971;215:478
75. Wilson RE, Hampers CL, et al: Subtotal parathyreoidectomy in chronic renal failure. A seven year experience in a dialysis and transplant program. Ann Surg 1971;174:640-652
76. Sitges-Serra A, Gores P, et al: Serum calcium as an early indicator for surgical treatment after renal transplantation. World J Surg 1986;10:661
77. Sitges-Serra A, Esteller E, et al: Indications and late results of subtotal parathyroidectomy for hyperparathyroidism after renal transplantation. World J Surg 1984;8:534-539